Literals
- ou:categoriaPDI
- I0504-PROFESOR TITULAR UNIVERSIDAD INTERINO
- aiiso:code
- 54b13f042978499cb0048028be35a861
- ou:dedicacionPDI
- TIEMPO COMPLETO
- ou:dialnetId
- 637110
- foaf:firstName
- JOSÉ MANUEL
- ou:indiceHscopus
- 12
- foaf:lastName
- VAGACE VALERO
- foaf:name
- JOSÉ MANUEL VAGACE VALERO
- vivo:scopusId
- 16318174400
Typed Literals
- ou:esDoctor
- True (xsd:boolean)
- ou:personalActual
- True (xsd:boolean)
Relations
- teach:teacherOf
- ou:tienePublicacion
- A new case of acquired haemophilia B in the context of liver autoimmune disease
- Adolescent cancer care: What has changed in Spain in the past decade?
- Aplastic anemia during treatment with albendazole [8]
- Assessment of Iron Status by Erythrocyte Ferritin in Uremic Patients With or Without Recombinant Human Erythropoietin Therapy
- Blastic plasmacytoid dendritic cell neoplasm
- Burkitt-like lymphoma with 11q aberration: A germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
- C>A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: A non-deletional mutation or polymorphism?
- Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma
- Changes in platelet count: A primary or secondary effect of rHu-EPO therapy?
- Chronic haemolytic anaemia because of pyruvate kinase (PK) deficiency in a child heterozygous for haemoglobin S and no clinical features of sickle cell disease
- Clinical relevance of erythrocyte ferritin in microcytic anemias
- Congenital dyserythropoietic anemia associated to a GATA1 mutation aggravated by pyruvate kinase deficiency
- Diagnostic and therapeutic challenges of primary autoimmune haemolytic anaemia in children
- Diagnostic utility of HFE variants in Spanish patients: Association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia
- Dihydrofolate reductase genetic polymorphisms affect methotrexate dose requirements in pediatric patients with acute lymphoblastic leukemia on maintenance therapy
- Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia
- Ethylenediaminetetraacetic acid-dependent pseudomacrocytosis
- Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia
- Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings
- Fotoféresis: nueva terapia inmunomoduladora para enfermedades mediadas por linfocitos T.
- Functional consequences of transferrin receptor-2 mutations causing hereditary hemochromatosis type 3
- Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)
- Hyperhaemolysis syndrome responsive to splenectomy in a patient with δβ-thalassaemia: A discussion on underlying mechanisms
- Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
- Infection caused by Fusarium species in non-neutropenic oncological patients [4]
- Management of iron deficiency in various clinical conditions and the role of intravenous iron: Recommendations of the Spanish Erythropathology Group of the Spanish Society of Haematology and Haemotherapy
- Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
- Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis
- Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies
- Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia
- Photopheresis: New immunomodulatory therapy for T-lymphocyte mediated diseases
- Recomendaciones para el abordaje del déficit de hierro: papel del hierro intravenoso
- Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: A case report
- Retinal toxic reactions following photopheresis
- Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
- Thalassemia diagnosis in a blood donor from a unique trimorphic red blood cell population observed in the recipient
- Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013
- ou:perteneceAGrupoInvestigacion
- ou:adscritoADepartamento
- ou:adscritoACentro
- ou:imparteDocenciaEnArea
Inverse Relations
- Has related: ou:directorTesis